KATHERINE BOWES: Open Payments
NPI 1508082181 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 70 payments from 16 companies in 2025. Trend: 2023 $1,199 · 2024 $1,759 · 2025 $1,319
Food & beverage: $1,265Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $222 |
| UCB, Inc. | 8 | $190 |
| ABBVIE INC. | 9 | $159 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| Lilly USA, LLC | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| PFIZER INC. | 4 | $76 |
| GENZYME CORPORATION | 3 | $62 |
| Galderma Laboratories, L.P. | 3 | $57 |
| STRATA Skin Sciences, Inc. | 6 | $57 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, COSENTYX, TALTZ, XTRAC, CIBINQO.
Industry payments across MD — which companies pay providers there.
